Jul 16, 2024
Comments to FDA: Antiplaque, Antigingivitis
Docket Number:
81N-033P
Comments regarding "Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph".
Issues: